Mary Ludlam
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$4.3MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 7, 2019 | NIH | SBIR Phase II Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding | $822K | CAIRN BIOSCIENCES INC |
| Aug 9, 2018 | NIH | SBIR Phase II Multiplexed high-content assay for toxicity profiling using live iPSC-derived cardiomyocyte lines with lineage-specific barcoding | $1.2M | CAIRN BIOSCIENCES INC |
| Aug 15, 2016 | NSF | SBIR Phase II SBIR Phase II: A novel multicolor cell line engineering platform that enables high-throughput microscopy-based screening of living cells for drug discovery | $910K | CAIRN BIOSCIENCES INC |
| Aug 9, 2016 | NSF | SBIR Phase II SBIR Phase II: A novel multicolor cell line engineering platform that enables high-throughput microscopy-based screening of living cells for drug discovery | $910K | CAIRN BIOSCIENCES INC |
| 2015 | NSF | SBIR Phase I SBIR Phase I: A novel multicolor cell line engineering platform that enables high-throughput microscopy-based screening of living cells for drug discovery | $150K | CAIRN BIOSCIENCES INC |
| — | NIH | SBIR Phase I A MICROFLUIDIC AND MACHINE LEARNING-ENABLED SMARTLAB FOR AUTONOMOUS REMOTE EXECUTION AND ITERATION OF MULTISCALE LIVE CELL ASSAYS FOR DRUG DISCOVERY | $332K | CAIRN BIOSCIENCES INC |
Peer ranks
Federal funding#345
Awards as PI#315
Patents#273
Companies
- CAIRN BIOSCIENCES INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.